How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy

Semin Radiat Oncol. 2023 Jan;33(1):76-81. doi: 10.1016/j.semradonc.2022.10.010.

Abstract

Organ preservation for muscle-invasive bladder cancer (MIBC) may use trimodality therapy. This includes transurethral resection followed by radiation therapy. Radiosensitization has become one of the standard of care approaches for MIBC with high rates of local disease control and overall survival. The goal of organ preservation is to treat MIBC while preserving a well-functioning natural bladder. Debate remains over the best way to optimize radiation therapy in bladder cancer. In MIBC the role of partial cystectomy has been utilized in smaller solitary tumors with adequate local control and good urinary function. As radiation therapy techniques improve and modernize, smaller radiation volumes to a partial bladder may play an increasing role as we utilize imaging techniques coupled with adaptive radiation therapy planning and other techniques such as brachytherapy. In this review, we explore the use of brachytherapy and partial bladder fields of external beam radiation therapy in the treatment of MIBC.

Publication types

  • Review

MeSH terms

  • Brachytherapy* / methods
  • Combined Modality Therapy
  • Cystectomy / methods
  • Humans
  • Neoplasm Invasiveness / pathology
  • Urinary Bladder / pathology
  • Urinary Bladder / surgery
  • Urinary Bladder Neoplasms* / radiotherapy
  • Urinary Bladder Neoplasms* / surgery